தண்டுவட மரப்பு நோய் (Tamil Wikipedia)

Compston A, Coles A (April 2002). "Multiple sclerosis". Lancet 359 (9313): 1221–31. doi:10.1016/S0140-6736(02)08220-X. பப்மெட்:11955556.
Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F (July 2008). "Natural history of multiple sclerosis in a population-based cohort". Eur. J. Neurol. 15 (9): 916. doi:10.1111/j.1468-1331.2008.02241.x. பப்மெட்:18637953.
Rosati G (April 2001). "The prevalence of multiple sclerosis in the world: an update". Neurol. Sci. 22 (2): 117–39. doi:10.1007/s100720170011. பப்மெட்:11603614.
Ascherio A, Munger KL (April 2007). "Environmental risk factors for multiple sclerosis. Part I: the role of infection". Ann. Neurol. 61 (4): 288–99. doi:10.1002/ana.21117. பப்மெட்:17444504. https://archive.org/details/sim_annals-of-neurology_2007-04_61_4/page/288.
Weinshenker BG (1994). "Natural history of multiple sclerosis". Ann. Neurol. 36 (Suppl): S6–11. doi:10.1002/ana.410360704. பப்மெட்:8017890.
Pittock SJ, Rodriguez M (2008). "Benign multiple sclerosis: a distinct clinical entity with therapeutic implications". Curr. Top. Microbiol. Immunol. 318: 1–17. doi:10.1007/978-3-540-73677-6_1. பப்மெட்:18219812.
Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M (April 2006). "Secondary progressive multiple sclerosis: current knowledge and future challenges". Lancet Neurol 5 (4): 343–54. doi:10.1016/S1474-4422(06)70410-0. பப்மெட்:16545751.
Miller DH, Leary SM (October 2007). "Primary-progressive multiple sclerosis". Lancet Neurol 6 (10): 903–12. doi:10.1016/S1474-4422(07)70243-0. பப்மெட்:17884680.
Capello E, Mancardi GL (November 2004). "Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis". Neurol. Sci. 25 (Suppl 4): S361–3. doi:10.1007/s10072-004-0341-1. பப்மெட்:15727234.
Hainfellner JA, Schmidbauer M, Schmutzhard E, Maier H, Budka H (December 1992). "Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis". J. Neurol. Neurosurg. Psychiatr. 55 (12): 1194–6. doi:10.1136/jnnp.55.12.1194. பப்மெட்:1343820.
Stark W, Huppke P, Gärtner J (December 2008). "Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence". J. Neurol. 255 (Suppl 6): 119–22. doi:10.1007/s00415-008-6022-x. பப்மெட்:19300972.
Miller D, Barkhof F, Montalban X, Thompson A, Filippi M (May 2005). "Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis". Lancet Neurol 4 (5): 281–8. doi:10.1016/S1474-4422(05)70071-5. பப்மெட்:15847841.
Jongen PJ (June 2006). "Psychiatric onset of multiple sclerosis". J. Neurol. Sci. 245 (1-2): 59–62. doi:10.1016/j.jns.2005.09.014. பப்மெட்:16631798.
Hakiki B, Goretti B, Portaccio E, Zipoli V, Amato MP (August 2008). "'Subclinical MS': follow-up of four cases". Eur. J. Neurol. 15 (8): 858–61. doi:10.1111/j.1468-1331.2008.02155.x. பப்மெட்:18507677.
Lebrun C, Bensa C, Debouverie M, et al (February 2008). "Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile". J. Neurol. Neurosurg. Psychiatr. 79 (2): 195–8. doi:10.1136/jnnp.2006.108274. பப்மெட்:18202208.
Petzold A, Fraser CL, Abegg M, et al. (December 2022). "Diagnosis and classification of optic neuritis". The Lancet Neurology 21 (12): 1120–1134. doi:10.1016/S1474-4422(22)00200-9. பப்மெட்:36179757.
Kaur P, Bennett JL (2007). "Optic neuritis and the neuro-ophthalmology of multiple sclerosis". Int. Rev. Neurobiol. 79: 633–663. doi:10.1016/S0074-7742(07)79028-1. பப்மெட்:17531862.
Pöllmann W, Feneberg W (2008). "Current management of pain associated with multiple sclerosis". CNS Drugs 22 (4): 291–324. doi:10.2165/00023210-200822040-00003. பப்மெட்:18336059.
Andrews KL, Husmann DA (December 1997). "Bladder dysfunction and management in multiple sclerosis". Mayo Clin. Proc. 72 (12): 1176–83. doi:10.4065/72.12.1176. பப்மெட்:9413302. https://archive.org/details/sim_mayo-clinic-proceedings_1997-12_72_12/page/1176.
Chiaravalloti ND, DeLuca J (December 2008). "Cognitive impairment in multiple sclerosis". Lancet Neurol 7 (12): 1139–51. doi:10.1016/S1474-4422(08)70259-X. பப்மெட்:19007738.
de Seze J, Zephir H, Hautecoeur P, Mackowiak A, Cabaret M, Vermersch P (November 2006). "Pathologic laughing and intractable hiccups can occur early in multiple sclerosis". Neurology 67 (9): 1684–6. doi:10.1212/01.wnl.0000242625.75753.69. பப்மெட்:17101907.
Tataru N, Vidal C, Decavel P, Berger E, Rumbach L (2006). "Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis". Neuroepidemiology 27 (1): 28–32. doi:10.1159/000094233. பப்மெட்:16804331.
Confavreux C (May 2002). "Infections and the risk of relapse in multiple sclerosis". Brain 125 (Pt 5): 933–4. doi:10.1093/brain/awf146. பப்மெட்:11960883. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11960883.
Buljevac D, Flach HZ, Hop WC, et al (May 2002). "Prospective study on the relationship between infections and multiple sclerosis exacerbations". Brain 125 (Pt 5): 952–60. doi:10.1093/brain/awf098. பப்மெட்:11960885. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11960885.
Buljevac D, Hop WC, Reedeker W, et al (September 2003). "Self reported stressful life events and exacerbations in multiple sclerosis: prospective study". BMJ 327 (7416): 646. doi:10.1136/bmj.327.7416.646. பப்மெட்:14500435.
Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD (August 2006). "Relationship between stress and relapse in multiple sclerosis: Part I. Important features". Mult. Scler. 12 (4): 453–64. doi:10.1191/1352458506ms1295oa. பப்மெட்:16900759. http://msj.sagepub.com/cgi/pmidlookup?view=long&pmid=16900759. பார்த்த நாள்: 2009-12-28.
Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD (August 2006). "Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships". Mult. Scler. 12 (4): 465–75. doi:10.1191/1352458506ms1296oa. பப்மெட்:16900760. http://msj.sagepub.com/cgi/pmidlookup?view=long&pmid=16900760. பார்த்த நாள்: 2009-12-28.
Worthington J, Jones R, Crawford M, Forti A (February 1994). "Pregnancy and multiple sclerosis--a 3-year prospective study". J. Neurol. 241 (4): 228–33. doi:10.1007/BF00863773. பப்மெட்:8195822. https://archive.org/details/sim_journal-of-neurology_1994-02_241_4/page/228.
Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S (February 2001). "Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group". N. Engl. J. Med. 344 (5): 319–26. doi:10.1056/NEJM200102013440501. பப்மெட்:11172162. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=11172162&promo=ONFLNS19.
Martinelli V (2000). "Trauma, stress and multiple sclerosis". Neurol. Sci. 21 (4 Suppl 2): S849–52. doi:10.1007/s100720070024. பப்மெட்:11205361. http://link.springer-ny.com/link/service/journals/10072/bibs/00214%20Suppl%202/0021S849.htm. பார்த்த நாள்: 2009-12-28.
Sibley WA, Bamford CR, Clark K, Smith MS, Laguna JF (July 1991). "A prospective study of physical trauma and multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 54 (7): 584–9. doi:10.1136/jnnp.54.7.584. பப்மெட்:1895121.
Smith KJ, McDonald WI (October 1999). "The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease". Philos. Trans. R. Soc. Lond., B, Biol. Sci. 354 (1390): 1649–73. doi:10.1098/rstb.1999.0510. பப்மெட்:10603618.
Dyment DA, Ebers GC, Sadovnick AD (Feb 2004). "Genetics of multiple sclerosis". Lancet Neurol 3 (92): 104–10. doi:10.1016/S1474-4422(03)00663-X. பப்மெட்:14747002.
Sadovnick AD, Ebers GC, Dyment DA, Risch NJ (June 1996). "Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group". Lancet 347 (9017): 1728–30. doi:10.1016/S0140-6736(96)90807-7. பப்மெட்:8656905.
Svejgaard A (June 2008). "The immunogenetics of multiple sclerosis". Immunogenetics 60 (6): 275–86. doi:10.1007/s00251-008-0295-1. பப்மெட்:18461312.
Hafler DA, Compston A, Sawcer S, et al (August 2007). "Risk alleles for multiple sclerosis identified by a genomewide study". N. Engl. J. Med. 357 (9): 851–62. doi:10.1056/NEJMoa073493. பப்மெட்:17660530. https://archive.org/details/sim_new-england-journal-of-medicine_2007-08-30_357_9/page/n27.
Weber F, Fontaine B, Cournu-Rebeix I, et al (April 2008). "IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations". Genes Immun. 9 (3): 259–63. doi:10.1038/gene.2008.14. பப்மெட்:18354419.
Anaya JM, Gómez L, Castiblanco J (2006). "Is there a common genetic basis for autoimmune diseases?". Clin. Dev. Immunol. 13 (2-4): 185–95. doi:10.1080/17402520600876762. பப்மெட்:17162361.
Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ (September 2008). "IL-21 signaling is critical for the development of type I diabetes in the NOD mouse". Proc. Natl. Acad. Sci. U.S.A. 105 (37): 14028. doi:10.1073/pnas.0804358105. பப்மெட்:18779574.
Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, et al (December 2008). "Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis". Nat. Genet. 40 (12): 1402–3. doi:10.1038/ng.251. பப்மெட்:18997785.
Palacios R, Aguirrezabal I, Fernandez-Diez B, Brieva L, Villoslada P (October 2005). "Chromosome 5 and multiple sclerosis". J. Neuroimmunol. 167 (1-2): 1–3. doi:10.1016/j.jneuroim.2005.06.023. பப்மெட்:16099057.
Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M (February 1966). "Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation". J. Neurol. Neurosurg. Psychiatr. 29 (1): 60–8. doi:10.1136/jnnp.29.1.60. பப்மெட்:5910580.
Fleming J, Fabry Z (February 2007). "The hygiene hypothesis and multiple sclerosis". Ann. Neurol. 61 (2): 85–9. doi:10.1002/ana.21092. பப்மெட்:17315205. https://archive.org/details/sim_annals-of-neurology_2007-02_61_2/page/85.
Gilden DH (March 2005). "Infectious causes of multiple sclerosis". Lancet Neurol 4 (3): 195–202. doi:10.1016/S1474-4422(05)01017-3. பப்மெட்:15721830.
Sotelo J, Martínez-Palomo A, Ordoñez G, Pineda B (March 2008). "Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis". Ann. Neurol. 63 (3): 303–11. doi:10.1002/ana.21316. பப்மெட்:18306233. https://archive.org/details/sim_annals-of-neurology_2008-03_63_3/page/303.
Lünemann JD, Kamradt T, Martin R, Münz C (July 2007). "Epstein-barr virus: environmental trigger of multiple sclerosis?". J. Virol. 81 (13): 6777–84. doi:10.1128/JVI.00153-07. பப்மெட்:17459939.
Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G. (May 2009). "Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI". Neurology 73 (1): 32–8. doi:10.1212/WNL.0b013e3181aa29fe. பப்மெட்:19458321.
Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C (October 2001). "Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases". Ann. Neurol. 50 (4): 434–42. doi:10.1002/ana.1131. பப்மெட்:11601494.
Marrie RA (December 2004). "Environmental risk factors in multiple sclerosis aetiology". Lancet Neurol 3 (12): 709–18. doi:10.1016/S1474-4422(04)00933-0. பப்மெட்:15556803.
Islam T, Gauderman WJ, Cozen W, Mack TM (July 2007). "Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins". Neurology 69 (4): 381–8. doi:10.1212/01.wnl.0000268266.50850.48. பப்மெட்:17646631. https://archive.org/details/sim_neurology_2007-07-24_69_4/page/n93.
van der Mei IA, Ponsonby AL, Dwyer T, et al (August 2003). "Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study". BMJ 327 (7410): 316. doi:10.1136/bmj.327.7410.316. பப்மெட்:12907484.
Ascherio A, Munger KL (June 2007). "Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors". Ann. Neurol. 61 (6): 504–13. doi:10.1002/ana.21141. பப்மெட்:17492755. https://archive.org/details/sim_annals-of-neurology_2007-06_61_6/page/504.
Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (December 2006). "Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis". JAMA 296 (23): 2832–8. doi:10.1001/jama.296.23.2832. பப்மெட்:17179460.
Koch M, De Keyser J (April 2006). "Uric acid in multiple sclerosis". Neurol. Res. 28 (3): 316–9. doi:10.1179/016164106X98215. பப்மெட்:16687059.
Spitsin S, Koprowski H (2008). "Role of uric acid in multiple sclerosis". Curr. Top. Microbiol. Immunol. 318: 325–42. doi:10.1007/978-3-540-73677-6_13. பப்மெட்:18219824.
Ascherio A, Munger K (February 2008). "Epidemiology of multiple sclerosis: from risk factors to prevention". Semin Neurol 28 (1): 17–28. doi:10.1055/s-2007-1019126. பப்மெட்:18256984.
Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M (July 2009). "White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis". J. Neurol. Sci. 282 (1-2): 28–33. doi:10.1016/j.jns.2008.12.036. பப்மெட்:19181347. http://linkinghub.elsevier.com/retrieve/pii/S0022-510X(08)00673-4.
Ge Y, Zohrabian VM, Grossman RI. (2008). "Seven-tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis". Archives of neurology 65 (6): 812–6. doi:10.1001/archneur.65.6.812. பப்மெட்:18541803.
Leech S, Kirk J, Plumb J, McQuaid S (2007). "Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis". Neuropathol. Appl. Neurobiol. 33 (1): 86–98. doi:10.1111/j.1365-2990.2006.00781.x. பப்மெட்:17239011.
Pascual AM, Martínez-Bisbal MC, Boscá I, et al (July 2007). "Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis". Neurology 69 (1): 63–7. doi:10.1212/01.wnl.0000265054.08610.12. பப்மெட்:17606882.
Chari DM (2007). "Remyelination in multiple sclerosis". Int. Rev. Neurobiol. 79: 589–620. doi:10.1016/S0074-7742(07)79026-8. பப்மெட்:17531860.
Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (June 2000). "Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination". Ann. Neurol. 47 (6): 707–17. doi:10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q. பப்மெட்:10852536. https://archive.org/details/sim_annals-of-neurology_2000-06_47_6/page/707.
Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, Lassmann H, Dornmair K, Kurschus FC, Liblau RS, Wekerle H (June 2009). "Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis". Nat. Med. 15 (6): 626–32. doi:10.1038/nm.1975. பப்மெட்:19483694. Lay summary – Max Planck Society.
Pöllinger B, Krishnamoorthy G, Berer K, Lassmann H, Bösl MR, Dunn R, Domingues HS, Holz A, Kurschus FC, Wekerle H (June 2009). "Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells". J. Exp. Med. 206 (6): 1303–16. doi:10.1084/jem.20090299. பப்மெட்:19487416.
Trojano M, Paolicelli D (November 2001). "The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes". Neurol. Sci. 22 (Suppl 2): S98–102. doi:10.1007/s100720100044. பப்மெட்:11794488. http://link.springer-ny.com/link/service/journals/10072/bibs/122%20Suppl%202000/122%20Suppl%2020S98.htm. பார்த்த நாள்: 2009-12-28.
Poser CM, Brinar VV (June 2004). "Diagnostic criteria for multiple sclerosis: an historical review". Clin Neurol Neurosurg 106 (3): 147–58. doi:10.1016/j.clineuro.2004.02.004. பப்மெட்:15177763.
McDonald WI, Compston A, Edan G, et al (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Ann. Neurol. 50 (1): 121–7. doi:10.1002/ana.1032. பப்மெட்:11456302. https://archive.org/details/sim_annals-of-neurology_2001-07_50_1/page/121.
Rashid W, Miller DH (February 2008). "Recent advances in neuroimaging of multiple sclerosis". Semin Neurol 28 (1): 46–55. doi:10.1055/s-2007-1019127. பப்மெட்:18256986.
Link H, Huang YM (November 2006). "Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness". J. Neuroimmunol. 180 (1-2): 17–28. doi:10.1016/j.jneuroim.2006.07.006. பப்மெட்:16945427.
Brusaferri F, Candelise L (2000). "Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials". J. Neurol. 247 (6): 435–42. doi:10.1007/s004150070172. பப்மெட்:10929272. https://archive.org/details/sim_journal-of-neurology_2000-06_247_6/page/435.
Dovio A, Perazzolo L, Osella G, et al (2004). "Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis". J. Clin. Endocrinol. Metab. 89 (10): 4923–8. doi:10.1210/jc.2004-0164. பப்மெட்:15472186.
Uttner I, Müller S, Zinser C, et al (2005). "Reversible impaired memory induced by pulsed methylprednisolone in patients with MS". Neurology 64 (11): 1971–3. doi:10.1212/01.WNL.0000163804.94163.91. பப்மெட்:15955958.
Jacobs LD, Beck RW, Simon JH, et al. (2000). "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group". N Engl J Med 343 (13): 898–904. doi:10.1056/NEJM200009283431301. பப்மெட்:11006365.
Comi G, Filippi M, Barkhof F, et al. (2001). "Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study". Lancet 357 (9268): 1576–82. doi:10.1016/S0140-6736(00)04725-5. பப்மெட்:11377645.
Kappos L, Freedman MS, Polman CH, et al. (2007). "Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study". Lancet 370 (9585): 389–97. doi:10.1016/S0140-6736(07)61194-5. பப்மெட்:17679016.
Ruggieri M, Avolio C, Livrea P, Trojano M (2007). "Glatiramer acetate in multiple sclerosis: a review". CNS Drug Rev 13 (2): 178–91. doi:10.1111/j.1527-3458.2007.00010.x. பப்மெட்:17627671.
Munari L, Lovati R, Boiko A (2004). "Therapy with glatiramer acetate for multiple sclerosis". Cochrane Database Syst Rev (1): CD004678. doi:10.1002/14651858.CD004678. பப்மெட்:14974077.
Rice GP, Incorvaia B, Munari L, et al (2001). "Interferon in relapsing-remitting multiple sclerosis". Cochrane Database Syst Rev (4): CD002002. doi:10.1002/14651858.CD002002. பப்மெட்:11687131.
Martinelli Boneschi F, Rovaris M, Capra R, Comi G (2005). "Mitoxantrone for multiple sclerosis". Cochrane Database Syst Rev (4): CD002127. doi:10.1002/14651858.CD002127.pub2. பப்மெட்:16235298.
Johnson KP (2007). "Control of multiple sclerosis relapses with immunomodulating agents". J. Neurol. Sci. 256 (Suppl 1): S23–8. doi:10.1016/j.jns.2007.01.060. பப்மெட்:17350652.
Gonsette RE (2007). "Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis". Expert opinion on pharmacotherapy 8 (8): 1103–16. doi:10.1517/14656566.8.8.1103. பப்மெட்:17516874.
Murray TJ (2006). "The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?". Expert opinion on drug safety 5 (2): 265–74. doi:10.1517/14740338.5.2.265. பப்மெட்:16503747.
Leary SM, Thompson AJ (2005). "Primary progressive multiple sclerosis: current and future treatment options". CNS drugs 19 (5): 369–76. doi:10.2165/00023210-200519050-00001. பப்மெட்:15907149.
Fox EJ (2006). "Management of worsening multiple sclerosis with mitoxantrone: a review". Clinical therapeutics 28 (4): 461–74. doi:10.1016/j.clinthera.2006.04.013. பப்மெட்:16750460.
Kleinschmidt-DeMasters BK, Tyler KL (2005). "Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis". N Engl J Med 353 (4): 369–74. doi:10.1056/NEJMoa051782. பப்மெட்:15947079. பதிவு செய்தால் இலவச முழு உரை
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005). "Progressive multifocal leukoencephalopathy in a patient treated with natalizumab". N Engl J Med 353 (4): 375–81. doi:10.1056/NEJMoa051847. பப்மெட்:15947078. http://content.nejm.org/cgi/content/abstract/353/4/375.
Kesselring J, Beer S (2005). "Symptomatic therapy and neurorehabilitation in multiple sclerosis". Lancet neurology 4 (10): 643–52. doi:10.1016/S1474-4422(05)70193-9. பப்மெட்:16168933.
Khan F, Turner-Stokes L, Ng L, Kilpatrick T (2007). "Multidisciplinary rehabilitation for adults with multiple sclerosis". Cochrane Database Syst Rev (2): CD006036. doi:10.1002/14651858.CD006036.pub2. பப்மெட்:17443610.
Khan F, Ng L, Turner-Stokes L (2009). "Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis". Cochrane Database Syst Rev (1): CD007256. doi:10.1002/14651858.CD007256.pub2. பப்மெட்:19160331.
Thomas PW, Thomas S, Hillier C, Galvin K, Baker R (2006). "Psychological interventions for multiple sclerosis". Cochrane Database Syst Rev (1): CD004431. doi:10.1002/14651858.CD004431.pub2. பப்மெட்:16437487.
Farinotti M, Simi S, Di Pietrantonj C, et al. (2007). "Dietary interventions for multiple sclerosis". Cochrane database of systematic reviews (Online) (1): CD004192. doi:10.1002/14651858.CD004192.pub2. பப்மெட்:17253500.
Chong MS, Wolff K, Wise K, Tanton C, Winstock A, Silber E (2006). "Cannabis use in patients with multiple sclerosis". Mult. Scler. 12 (5): 646–51. doi:10.1177/1352458506070947. பப்மெட்:17086912.
Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ (2005). "Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up". J. Neurol. Neurosurg. Psychiatr. 76 (12): 1664–9. doi:10.1136/jnnp.2005.070136. பப்மெட்:16291891.
Bennett M, Heard R (2004). "Hyperbaric oxygen therapy for multiple sclerosis". Cochrane database of systematic reviews (Online) (1): CD003057. doi:10.1002/14651858.CD003057.pub2. பப்மெட்:14974004.
Phadke JG (May 1987). "Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland". J. Neurol. Neurosurg. Psychiatr. 50 (5): 523–31. doi:10.1136/jnnp.50.5.523. பப்மெட்:3495637.
Stern M (February 2005). "Aging with multiple sclerosis". Phys Med Rehabil Clin N Am 16 (1): 219–34. doi:10.1016/j.pmr.2004.06.010. பப்மெட்:15561552.
Brissaud O, Palin K, Chateil JF, Pedespan JM (September 2001). "Multiple sclerosis: pathogenesis and manifestations in children" (in French). Arch Pediatr 8 (9): 969–78. doi:10.1016/S0929-693X(01)00564-4. பப்மெட்:11582940.
Alonso A, Hernán MA (July 2008). "Temporal trends in the incidence of multiple sclerosis: a systematic review". Neurology 71 (2): 129–35. doi:10.1212/01.wnl.0000316802.35974.34. பப்மெட்:18606967.
Aladro Y, Alemany MJ, Pérez-Vieitez MC, et al (2005). "Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain". Neuroepidemiology 24 (1-2): 70–5. doi:10.1159/000081052. பப்மெட்:15459512.
Pugliatti M, Sotgiu S, Solinas G, Castiglia P, Rosati G (April 2001). "Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory". Neurol. Sci. 22 (2): 163–5. doi:10.1007/s100720170017. பப்மெட்:11603620. http://link.springer-ny.com/link/service/journals/10072/bibs/1022002/10220163.htm. ^{[தொடர்பிழந்த இணைப்பு]}
Hammond SR, English DR, McLeod JG (May 2000). "The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia". Brain 123 (Pt 5): 968–74. doi:10.1093/brain/123.5.968. பப்மெட்:10775541. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=10775541.
Rothwell PM, Charlton D (1998). "High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition". J. Neurol. Neurosurg. Psychiatr. 64 (6): 730–5. doi:10.1136/jnnp.64.6.730. பப்மெட்:9647300. https://archive.org/details/sim_journal-of-neurology-neurosurgery-and-psychiatry_1998-06_64_6/page/730.
Compston A (October 1988). "The 150th anniversary of the first depiction of the lesions of multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 51 (10): 1249–52. doi:10.1136/jnnp.51.10.1249. பப்மெட்:3066846.
Holmøy T (2006). "A Norse contribution to the history of neurological diseases". Eur. Neurol. 55 (1): 57–8. doi:10.1159/000091431. பப்மெட்:16479124.
Pearce JM (2005). "Historical descriptions of multiple sclerosis". Eur. Neurol. 54 (1): 49–53. doi:10.1159/000087387. பப்மெட்:16103678.
The CAMMS223 Trial Investigators (2008). "Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis". N Engl J Med 359 (17): 1786–1801. doi:10.1056/NEJMoa0802670. பப்மெட்:18946064.
Agrawal YP (2005). "Low dose naltrexone therapy in multiple sclerosis". Med. Hypotheses 64 (4): 721–4. doi:10.1016/j.mehy.2004.09.024. பப்மெட்:15694688.
Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G (2008). "A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.". Multiple Sclerosis 14 (8): 1076–83. doi:10.1177/1352458508095828. பப்மெட்:18728058.
Albrecht P, Fröhlich R, Hartung HP, Kieseier BC, Methner A (2007). "Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis". J Neurol Online (11): 1595. doi:10.1007/s00415-007-0538-3. பப்மெட்:17987252.
Gordon-Lipkin E, Chodkowski B, Reich DS et al (October 2007). "Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis". Neurology 69 (16): 1603–09. doi:10.1212/01.wnl.0000295995.46586.ae. பப்மெட்:17938370.
Zamboni P, Galeotti R, Menegatti E, et al. (April 2009). "Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 80 (4): 392–9. doi:10.1136/jnnp.2008.157164. பப்மெட்:19060024. பப்மெட் சென்ட்ரல்:2647682. http://jnnp.bmj.com/cgi/content/full/80/4/392.
Thangarajh M, Gomez-Rial J, Hedström AK, et al (August 2008). "Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis". Mult. Scler. 14 (9): 1208. doi:10.1177/1352458508095729. பப்மெட்:18755821.

elsevier.com

linkinghub.elsevier.com

Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M (July 2009). "White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis". J. Neurol. Sci. 282 (1-2): 28–33. doi:10.1016/j.jns.2008.12.036. பப்மெட்:19181347. http://linkinghub.elsevier.com/retrieve/pii/S0022-510X(08)00673-4.

genzyme.com

ஜென்சைம் மற்றும் பேயர் ஹெல்த்கேர், மல்ட்டிபிள் ஸ்களீரோசிஸ் நோய்க்கு அலேம்துசூமாப் மருந்தை பயன்படுத்துதல் குறித்த தமது இரண்டு வருட ஆய்வுத் தகவலை ஏஏஎன் -க்கு அளித்தது. ஜென்சைம் (2007-02-01). 2007-11-22இல் திரும்ப எடுக்கப்பட்டது.

masson.fr

Fontaine B (September 2001). "[Borderline forms of multiple sclerosis"] (in French). Rev. Neurol. (Paris) 157 (8-9 Pt 2): 929–34. பப்மெட்:11787357. http://www.masson.fr/masson/MDOI-RN-09-2001-157-8-9-0035-3787-101019-ART68.

mpg.de

Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, Lassmann H, Dornmair K, Kurschus FC, Liblau RS, Wekerle H (June 2009). "Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis". Nat. Med. 15 (6): 626–32. doi:10.1038/nm.1975. பப்மெட்:19483694. Lay summary – Max Planck Society.

msforumonline.net

Christensen T (June 2007). "Human herpesviruses in MS" (PDF). Int MS J 14 (2): 41–7. பப்மெட்:17686342. http://www.msforumonline.net/journal/download/default.aspx?pdf=20071441.pdf. ^{[தொடர்பிழந்த இணைப்பு]}
Christensen T (May 2006). "The role of EBV in MS pathogenesis" (PDF). Int MS J 13 (2): 52–7. பப்மெட்:16635422. http://www.msforumonline.net/journal/download/default.aspx?pdf=20061352.pdf. ^{[தொடர்பிழந்த இணைப்பு]}

mxga-mstrial.co.uk

யுனைடெட் கிங்டெம் மைடோசான்ட்ரோன் கோபக்சோன் சிகிச்சை முறை. பரணிடப்பட்டது 2015-06-01 at the வந்தவழி இயந்திரம் ஓனிக்ஸ் ஹெல்த்கேர் (2006-01-01). 2007-11-22இல் திரும்ப எடுக்கப்பட்டது.

nejm.org

content.nejm.org

Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S (February 2001). "Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group". N. Engl. J. Med. 344 (5): 319–26. doi:10.1056/NEJM200102013440501. பப்மெட்:11172162. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=11172162&promo=ONFLNS19.
Kleinschmidt-DeMasters BK, Tyler KL (2005). "Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis". N Engl J Med 353 (4): 369–74. doi:10.1056/NEJMoa051782. பப்மெட்:15947079. பதிவு செய்தால் இலவச முழு உரை
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005). "Progressive multifocal leukoencephalopathy in a patient treated with natalizumab". N Engl J Med 353 (4): 375–81. doi:10.1056/NEJMoa051847. பப்மெட்:15947078. http://content.nejm.org/cgi/content/abstract/353/4/375.

neurology.org

Yao SY, Stratton CW, Mitchell WM, Sriram S (May 2001). "CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens". Neurology 56 (9): 1168–76. பப்மெட்:11342681. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=11342681.
Li J, Johansen C, Brønnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J (March 2004). "The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark". Neurology 62 (5): 726–9. பப்மெட்:15007121. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=15007121.
Franklin GM, Nelson L (October 2003). "Environmental risk factors in multiple sclerosis: causes, triggers, and patient autonomy". Neurology 61 (8): 1032–4. பப்மெட்:14581658. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=14581658.
Gronseth GS, Ashman EJ (May 2000). "Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology 54 (9): 1720–5. பப்மெட்:10802774. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=10802774.

neurologyreviews.com

"Some MS Patients have "Dramatic" Responses to Plasma Exchange". Neurology Reviews.com. March 2000. Archived from the original on 2009-08-07. Retrieved 2009-07-10.

nih.gov

ncbi.nlm.nih.gov

Compston A, Coles A (April 2002). "Multiple sclerosis". Lancet 359 (9313): 1221–31. doi:10.1016/S0140-6736(02)08220-X. பப்மெட்:11955556.
Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F (July 2008). "Natural history of multiple sclerosis in a population-based cohort". Eur. J. Neurol. 15 (9): 916. doi:10.1111/j.1468-1331.2008.02241.x. பப்மெட்:18637953.
Rosati G (April 2001). "The prevalence of multiple sclerosis in the world: an update". Neurol. Sci. 22 (2): 117–39. doi:10.1007/s100720170011. பப்மெட்:11603614.
Ascherio A, Munger KL (April 2007). "Environmental risk factors for multiple sclerosis. Part I: the role of infection". Ann. Neurol. 61 (4): 288–99. doi:10.1002/ana.21117. பப்மெட்:17444504. https://archive.org/details/sim_annals-of-neurology_2007-04_61_4/page/288.
Lublin FD, Reingold SC (April 1996). "Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis". Neurology 46 (4): 907–11. பப்மெட்:8780061. https://archive.org/details/sim_neurology_1996-04_46_4/page/907.
Weinshenker BG (1994). "Natural history of multiple sclerosis". Ann. Neurol. 36 (Suppl): S6–11. doi:10.1002/ana.410360704. பப்மெட்:8017890.
Pittock SJ, Rodriguez M (2008). "Benign multiple sclerosis: a distinct clinical entity with therapeutic implications". Curr. Top. Microbiol. Immunol. 318: 1–17. doi:10.1007/978-3-540-73677-6_1. பப்மெட்:18219812.
Rovaris M, Confavreux C, Furlan R, Kappos L, Comi G, Filippi M (April 2006). "Secondary progressive multiple sclerosis: current knowledge and future challenges". Lancet Neurol 5 (4): 343–54. doi:10.1016/S1474-4422(06)70410-0. பப்மெட்:16545751.
Miller DH, Leary SM (October 2007). "Primary-progressive multiple sclerosis". Lancet Neurol 6 (10): 903–12. doi:10.1016/S1474-4422(07)70243-0. பப்மெட்:17884680.
Fontaine B (September 2001). "[Borderline forms of multiple sclerosis"] (in French). Rev. Neurol. (Paris) 157 (8-9 Pt 2): 929–34. பப்மெட்:11787357. http://www.masson.fr/masson/MDOI-RN-09-2001-157-8-9-0035-3787-101019-ART68.
Capello E, Mancardi GL (November 2004). "Marburg type and Balò's concentric sclerosis: rare and acute variants of multiple sclerosis". Neurol. Sci. 25 (Suppl 4): S361–3. doi:10.1007/s10072-004-0341-1. பப்மெட்:15727234.
Hainfellner JA, Schmidbauer M, Schmutzhard E, Maier H, Budka H (December 1992). "Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis". J. Neurol. Neurosurg. Psychiatr. 55 (12): 1194–6. doi:10.1136/jnnp.55.12.1194. பப்மெட்:1343820.
Stark W, Huppke P, Gärtner J (December 2008). "Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence". J. Neurol. 255 (Suppl 6): 119–22. doi:10.1007/s00415-008-6022-x. பப்மெட்:19300972.
O'Riordan JI (June 1997). "Central nervous system white matter diseases other than multiple sclerosis". Curr. Opin. Neurol. 10 (3): 211–4. பப்மெட்:9229127.
Miller D, Barkhof F, Montalban X, Thompson A, Filippi M (May 2005). "Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis". Lancet Neurol 4 (5): 281–8. doi:10.1016/S1474-4422(05)70071-5. பப்மெட்:15847841.
Santos EC, Yokota M, Dias NF (September 2007). "[Multiple sclerosis: study of patients with relapsing-remitting form registered at Minas Gerais Secretary of State for Health"] (in Portuguese). Arq Neuropsiquiatr 65 (3B): 885–8. பப்மெட்:17952303. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2007000500032&lng=en&nrm=iso&tlng=en.
Navarro S, Mondéjar-Marín B, Pedrosa-Guerrero A, Pérez-Molina I, Garrido-Robres JA, Alvarez-Tejerina A (2005). "[Aphasia and parietal syndrome as the presenting symptoms of a demyelinating disease with pseudotumoral lesions"] (in Spanish; Castilian). Rev Neurol 41 (10): 601–3. பப்மெட்:16288423. http://www.revneurol.com/LinkOut/formMedLine.asp?Refer=2005523&Revista=RevNeurol.
Jongen PJ (June 2006). "Psychiatric onset of multiple sclerosis". J. Neurol. Sci. 245 (1-2): 59–62. doi:10.1016/j.jns.2005.09.014. பப்மெட்:16631798.
Yetimalar Y, Seçil Y, Inceoglu AK, Eren S, Başoğlu M (July 2008). "Unusual primary manifestations of multiple sclerosis". N. Z. Med. J. 121 (1277): 47–59. பப்மெட்:18677330.
Hakiki B, Goretti B, Portaccio E, Zipoli V, Amato MP (August 2008). "'Subclinical MS': follow-up of four cases". Eur. J. Neurol. 15 (8): 858–61. doi:10.1111/j.1468-1331.2008.02155.x. பப்மெட்:18507677.
Lebrun C, Bensa C, Debouverie M, et al (February 2008). "Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile". J. Neurol. Neurosurg. Psychiatr. 79 (2): 195–8. doi:10.1136/jnnp.2006.108274. பப்மெட்:18202208.
Petzold A, Fraser CL, Abegg M, et al. (December 2022). "Diagnosis and classification of optic neuritis". The Lancet Neurology 21 (12): 1120–1134. doi:10.1016/S1474-4422(22)00200-9. பப்மெட்:36179757.
Merson RM, Rolnick MI (August 1998). "Speech-language pathology and dysphagia in multiple sclerosis". Phys Med Rehabil Clin N Am 9 (3): 631–641. பப்மெட்:9894114.
Kaur P, Bennett JL (2007). "Optic neuritis and the neuro-ophthalmology of multiple sclerosis". Int. Rev. Neurobiol. 79: 633–663. doi:10.1016/S0074-7742(07)79028-1. பப்மெட்:17531862.
Pöllmann W, Feneberg W (2008). "Current management of pain associated with multiple sclerosis". CNS Drugs 22 (4): 291–324. doi:10.2165/00023210-200822040-00003. பப்மெட்:18336059.
Henze T (August 2005). "Managing specific symptoms in people with multiple sclerosis". Int MS J 12 (2): 60–8. பப்மெட்:16417816.
Andrews KL, Husmann DA (December 1997). "Bladder dysfunction and management in multiple sclerosis". Mayo Clin. Proc. 72 (12): 1176–83. doi:10.4065/72.12.1176. பப்மெட்:9413302. https://archive.org/details/sim_mayo-clinic-proceedings_1997-12_72_12/page/1176.
Chiaravalloti ND, DeLuca J (December 2008). "Cognitive impairment in multiple sclerosis". Lancet Neurol 7 (12): 1139–51. doi:10.1016/S1474-4422(08)70259-X. பப்மெட்:19007738.
de Seze J, Zephir H, Hautecoeur P, Mackowiak A, Cabaret M, Vermersch P (November 2006). "Pathologic laughing and intractable hiccups can occur early in multiple sclerosis". Neurology 67 (9): 1684–6. doi:10.1212/01.wnl.0000242625.75753.69. பப்மெட்:17101907.
Kurtzke JF (1983). "Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)". Neurology 33 (11): 1444–52. பப்மெட்:6685237. https://archive.org/details/sim_neurology_1983-11_33_11/page/1444.
Tataru N, Vidal C, Decavel P, Berger E, Rumbach L (2006). "Limited impact of the summer heat wave in France (2003) on hospital admissions and relapses for multiple sclerosis". Neuroepidemiology 27 (1): 28–32. doi:10.1159/000094233. பப்மெட்:16804331.
Confavreux C (May 2002). "Infections and the risk of relapse in multiple sclerosis". Brain 125 (Pt 5): 933–4. doi:10.1093/brain/awf146. பப்மெட்:11960883. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11960883.
Buljevac D, Flach HZ, Hop WC, et al (May 2002). "Prospective study on the relationship between infections and multiple sclerosis exacerbations". Brain 125 (Pt 5): 952–60. doi:10.1093/brain/awf098. பப்மெட்:11960885. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11960885.
Buljevac D, Hop WC, Reedeker W, et al (September 2003). "Self reported stressful life events and exacerbations in multiple sclerosis: prospective study". BMJ 327 (7416): 646. doi:10.1136/bmj.327.7416.646. பப்மெட்:14500435.
Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD (August 2006). "Relationship between stress and relapse in multiple sclerosis: Part I. Important features". Mult. Scler. 12 (4): 453–64. doi:10.1191/1352458506ms1295oa. பப்மெட்:16900759. http://msj.sagepub.com/cgi/pmidlookup?view=long&pmid=16900759. பார்த்த நாள்: 2009-12-28.
Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD (August 2006). "Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships". Mult. Scler. 12 (4): 465–75. doi:10.1191/1352458506ms1296oa. பப்மெட்:16900760. http://msj.sagepub.com/cgi/pmidlookup?view=long&pmid=16900760. பார்த்த நாள்: 2009-12-28.
Worthington J, Jones R, Crawford M, Forti A (February 1994). "Pregnancy and multiple sclerosis--a 3-year prospective study". J. Neurol. 241 (4): 228–33. doi:10.1007/BF00863773. பப்மெட்:8195822. https://archive.org/details/sim_journal-of-neurology_1994-02_241_4/page/228.
Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S (February 2001). "Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group". N. Engl. J. Med. 344 (5): 319–26. doi:10.1056/NEJM200102013440501. பப்மெட்:11172162. http://content.nejm.org/cgi/pmidlookup?view=short&pmid=11172162&promo=ONFLNS19.
Martinelli V (2000). "Trauma, stress and multiple sclerosis". Neurol. Sci. 21 (4 Suppl 2): S849–52. doi:10.1007/s100720070024. பப்மெட்:11205361. http://link.springer-ny.com/link/service/journals/10072/bibs/00214%20Suppl%202/0021S849.htm. பார்த்த நாள்: 2009-12-28.
Sibley WA, Bamford CR, Clark K, Smith MS, Laguna JF (July 1991). "A prospective study of physical trauma and multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 54 (7): 584–9. doi:10.1136/jnnp.54.7.584. பப்மெட்:1895121.
Smith KJ, McDonald WI (October 1999). "The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease". Philos. Trans. R. Soc. Lond., B, Biol. Sci. 354 (1390): 1649–73. doi:10.1098/rstb.1999.0510. பப்மெட்:10603618.
Dyment DA, Ebers GC, Sadovnick AD (Feb 2004). "Genetics of multiple sclerosis". Lancet Neurol 3 (92): 104–10. doi:10.1016/S1474-4422(03)00663-X. பப்மெட்:14747002.
Sadovnick AD, Ebers GC, Dyment DA, Risch NJ (June 1996). "Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group". Lancet 347 (9017): 1728–30. doi:10.1016/S0140-6736(96)90807-7. பப்மெட்:8656905.
Svejgaard A (June 2008). "The immunogenetics of multiple sclerosis". Immunogenetics 60 (6): 275–86. doi:10.1007/s00251-008-0295-1. பப்மெட்:18461312.
Hafler DA, Compston A, Sawcer S, et al (August 2007). "Risk alleles for multiple sclerosis identified by a genomewide study". N. Engl. J. Med. 357 (9): 851–62. doi:10.1056/NEJMoa073493. பப்மெட்:17660530. https://archive.org/details/sim_new-england-journal-of-medicine_2007-08-30_357_9/page/n27.
Weber F, Fontaine B, Cournu-Rebeix I, et al (April 2008). "IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations". Genes Immun. 9 (3): 259–63. doi:10.1038/gene.2008.14. பப்மெட்:18354419.
Anaya JM, Gómez L, Castiblanco J (2006). "Is there a common genetic basis for autoimmune diseases?". Clin. Dev. Immunol. 13 (2-4): 185–95. doi:10.1080/17402520600876762. பப்மெட்:17162361.
Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ (September 2008). "IL-21 signaling is critical for the development of type I diabetes in the NOD mouse". Proc. Natl. Acad. Sci. U.S.A. 105 (37): 14028. doi:10.1073/pnas.0804358105. பப்மெட்:18779574.
Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, et al (December 2008). "Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis". Nat. Genet. 40 (12): 1402–3. doi:10.1038/ng.251. பப்மெட்:18997785.
Palacios R, Aguirrezabal I, Fernandez-Diez B, Brieva L, Villoslada P (October 2005). "Chromosome 5 and multiple sclerosis". J. Neuroimmunol. 167 (1-2): 1–3. doi:10.1016/j.jneuroim.2005.06.023. பப்மெட்:16099057.
Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M (February 1966). "Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation". J. Neurol. Neurosurg. Psychiatr. 29 (1): 60–8. doi:10.1136/jnnp.29.1.60. பப்மெட்:5910580.
Fleming J, Fabry Z (February 2007). "The hygiene hypothesis and multiple sclerosis". Ann. Neurol. 61 (2): 85–9. doi:10.1002/ana.21092. பப்மெட்:17315205. https://archive.org/details/sim_annals-of-neurology_2007-02_61_2/page/85.
Kurtzke JF (October 1993). "Epidemiologic evidence for multiple sclerosis as an infection". Clin. Microbiol. Rev. 6 (4): 382–427. பப்மெட்:8269393. பப்மெட் சென்ட்ரல்:358295. http://cmr.asm.org/cgi/pmidlookup?view=long&pmid=8269393. பார்த்த நாள்: 2009-12-28.
Gilden DH (March 2005). "Infectious causes of multiple sclerosis". Lancet Neurol 4 (3): 195–202. doi:10.1016/S1474-4422(05)01017-3. பப்மெட்:15721830.
Christensen T (June 2007). "Human herpesviruses in MS" (PDF). Int MS J 14 (2): 41–7. பப்மெட்:17686342. http://www.msforumonline.net/journal/download/default.aspx?pdf=20071441.pdf. ^{[தொடர்பிழந்த இணைப்பு]}
Sotelo J, Martínez-Palomo A, Ordoñez G, Pineda B (March 2008). "Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis". Ann. Neurol. 63 (3): 303–11. doi:10.1002/ana.21316. பப்மெட்:18306233. https://archive.org/details/sim_annals-of-neurology_2008-03_63_3/page/303.
Lünemann JD, Kamradt T, Martin R, Münz C (July 2007). "Epstein-barr virus: environmental trigger of multiple sclerosis?". J. Virol. 81 (13): 6777–84. doi:10.1128/JVI.00153-07. பப்மெட்:17459939.
Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, Khaleeli Z, Schmierer K, Miller DH, Giovannoni G. (May 2009). "Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI". Neurology 73 (1): 32–8. doi:10.1212/WNL.0b013e3181aa29fe. பப்மெட்:19458321.
Johnston JB, Silva C, Holden J, Warren KG, Clark AW, Power C (October 2001). "Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases". Ann. Neurol. 50 (4): 434–42. doi:10.1002/ana.1131. பப்மெட்:11601494.
Christensen T (May 2006). "The role of EBV in MS pathogenesis" (PDF). Int MS J 13 (2): 52–7. பப்மெட்:16635422. http://www.msforumonline.net/journal/download/default.aspx?pdf=20061352.pdf. ^{[தொடர்பிழந்த இணைப்பு]}
Yao SY, Stratton CW, Mitchell WM, Sriram S (May 2001). "CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens". Neurology 56 (9): 1168–76. பப்மெட்:11342681. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=11342681.
Marrie RA (December 2004). "Environmental risk factors in multiple sclerosis aetiology". Lancet Neurol 3 (12): 709–18. doi:10.1016/S1474-4422(04)00933-0. பப்மெட்:15556803.
Islam T, Gauderman WJ, Cozen W, Mack TM (July 2007). "Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins". Neurology 69 (4): 381–8. doi:10.1212/01.wnl.0000268266.50850.48. பப்மெட்:17646631. https://archive.org/details/sim_neurology_2007-07-24_69_4/page/n93.
van der Mei IA, Ponsonby AL, Dwyer T, et al (August 2003). "Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study". BMJ 327 (7410): 316. doi:10.1136/bmj.327.7410.316. பப்மெட்:12907484.
Ascherio A, Munger KL (June 2007). "Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors". Ann. Neurol. 61 (6): 504–13. doi:10.1002/ana.21141. பப்மெட்:17492755. https://archive.org/details/sim_annals-of-neurology_2007-06_61_6/page/504.
Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (December 2006). "Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis". JAMA 296 (23): 2832–8. doi:10.1001/jama.296.23.2832. பப்மெட்:17179460.
Li J, Johansen C, Brønnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J (March 2004). "The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark". Neurology 62 (5): 726–9. பப்மெட்:15007121. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=15007121.
Franklin GM, Nelson L (October 2003). "Environmental risk factors in multiple sclerosis: causes, triggers, and patient autonomy". Neurology 61 (8): 1032–4. பப்மெட்:14581658. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=14581658.
Koch M, De Keyser J (April 2006). "Uric acid in multiple sclerosis". Neurol. Res. 28 (3): 316–9. doi:10.1179/016164106X98215. பப்மெட்:16687059.
Spitsin S, Koprowski H (2008). "Role of uric acid in multiple sclerosis". Curr. Top. Microbiol. Immunol. 318: 325–42. doi:10.1007/978-3-540-73677-6_13. பப்மெட்:18219824.
Mattle HP, Lienert C, Greeve I (September 2004). "[Uric acid and multiple sclerosis]" (in German). Ther Umsch 61 (9): 553–5. பப்மெட்:15493114.
Ascherio A, Munger K (February 2008). "Epidemiology of multiple sclerosis: from risk factors to prevention". Semin Neurol 28 (1): 17–28. doi:10.1055/s-2007-1019126. பப்மெட்:18256984.
Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M (July 2009). "White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis". J. Neurol. Sci. 282 (1-2): 28–33. doi:10.1016/j.jns.2008.12.036. பப்மெட்:19181347. http://linkinghub.elsevier.com/retrieve/pii/S0022-510X(08)00673-4.
Ge Y, Zohrabian VM, Grossman RI. (2008). "Seven-tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis". Archives of neurology 65 (6): 812–6. doi:10.1001/archneur.65.6.812. பப்மெட்:18541803.
Leech S, Kirk J, Plumb J, McQuaid S (2007). "Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis". Neuropathol. Appl. Neurobiol. 33 (1): 86–98. doi:10.1111/j.1365-2990.2006.00781.x. பப்மெட்:17239011.
Simka M (May 2009). "Blood brain barrier compromise with endothelial inflammation may lead to autoimmune loss of myelin during multiple sclerosis". Curr Neurovasc Res 6 (2): 132–9. பப்மெட்:19442163.
Pascual AM, Martínez-Bisbal MC, Boscá I, et al (July 2007). "Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis". Neurology 69 (1): 63–7. doi:10.1212/01.wnl.0000265054.08610.12. பப்மெட்:17606882.
Chari DM (2007). "Remyelination in multiple sclerosis". Int. Rev. Neurobiol. 79: 589–620. doi:10.1016/S0074-7742(07)79026-8. பப்மெட்:17531860.
Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (June 2000). "Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination". Ann. Neurol. 47 (6): 707–17. doi:10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q. பப்மெட்:10852536. https://archive.org/details/sim_annals-of-neurology_2000-06_47_6/page/707.
Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, Lassmann H, Dornmair K, Kurschus FC, Liblau RS, Wekerle H (June 2009). "Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis". Nat. Med. 15 (6): 626–32. doi:10.1038/nm.1975. பப்மெட்:19483694. Lay summary – Max Planck Society.
Pöllinger B, Krishnamoorthy G, Berer K, Lassmann H, Bösl MR, Dunn R, Domingues HS, Holz A, Kurschus FC, Wekerle H (June 2009). "Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells". J. Exp. Med. 206 (6): 1303–16. doi:10.1084/jem.20090299. பப்மெட்:19487416.
Trojano M, Paolicelli D (November 2001). "The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes". Neurol. Sci. 22 (Suppl 2): S98–102. doi:10.1007/s100720100044. பப்மெட்:11794488. http://link.springer-ny.com/link/service/journals/10072/bibs/122%20Suppl%202000/122%20Suppl%2020S98.htm. பார்த்த நாள்: 2009-12-28.
Poser CM, Brinar VV (June 2004). "Diagnostic criteria for multiple sclerosis: an historical review". Clin Neurol Neurosurg 106 (3): 147–58. doi:10.1016/j.clineuro.2004.02.004. பப்மெட்:15177763.
McDonald WI, Compston A, Edan G, et al (July 2001). "Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis". Ann. Neurol. 50 (1): 121–7. doi:10.1002/ana.1032. பப்மெட்:11456302. https://archive.org/details/sim_annals-of-neurology_2001-07_50_1/page/121.
Rashid W, Miller DH (February 2008). "Recent advances in neuroimaging of multiple sclerosis". Semin Neurol 28 (1): 46–55. doi:10.1055/s-2007-1019127. பப்மெட்:18256986.
Link H, Huang YM (November 2006). "Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness". J. Neuroimmunol. 180 (1-2): 17–28. doi:10.1016/j.jneuroim.2006.07.006. பப்மெட்:16945427.
Gronseth GS, Ashman EJ (May 2000). "Practice parameter: the usefulness of evoked potentials in identifying clinically silent lesions in patients with suspected multiple sclerosis (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology 54 (9): 1720–5. பப்மெட்:10802774. http://www.neurology.org/cgi/pmidlookup?view=long&pmid=10802774.
Brusaferri F, Candelise L (2000). "Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials". J. Neurol. 247 (6): 435–42. doi:10.1007/s004150070172. பப்மெட்:10929272. https://archive.org/details/sim_journal-of-neurology_2000-06_247_6/page/435.
Dovio A, Perazzolo L, Osella G, et al (2004). "Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis". J. Clin. Endocrinol. Metab. 89 (10): 4923–8. doi:10.1210/jc.2004-0164. பப்மெட்:15472186.
Uttner I, Müller S, Zinser C, et al (2005). "Reversible impaired memory induced by pulsed methylprednisolone in patients with MS". Neurology 64 (11): 1971–3. doi:10.1212/01.WNL.0000163804.94163.91. பப்மெட்:15955958.
Jacobs LD, Beck RW, Simon JH, et al. (2000). "Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group". N Engl J Med 343 (13): 898–904. doi:10.1056/NEJM200009283431301. பப்மெட்:11006365.
Comi G, Filippi M, Barkhof F, et al. (2001). "Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study". Lancet 357 (9268): 1576–82. doi:10.1016/S0140-6736(00)04725-5. பப்மெட்:11377645.
Kappos L, Freedman MS, Polman CH, et al. (2007). "Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study". Lancet 370 (9585): 389–97. doi:10.1016/S0140-6736(07)61194-5. பப்மெட்:17679016.
Ruggieri M, Avolio C, Livrea P, Trojano M (2007). "Glatiramer acetate in multiple sclerosis: a review". CNS Drug Rev 13 (2): 178–91. doi:10.1111/j.1527-3458.2007.00010.x. பப்மெட்:17627671.
Munari L, Lovati R, Boiko A (2004). "Therapy with glatiramer acetate for multiple sclerosis". Cochrane Database Syst Rev (1): CD004678. doi:10.1002/14651858.CD004678. பப்மெட்:14974077.
Rice GP, Incorvaia B, Munari L, et al (2001). "Interferon in relapsing-remitting multiple sclerosis". Cochrane Database Syst Rev (4): CD002002. doi:10.1002/14651858.CD002002. பப்மெட்:11687131.
Martinelli Boneschi F, Rovaris M, Capra R, Comi G (2005). "Mitoxantrone for multiple sclerosis". Cochrane Database Syst Rev (4): CD002127. doi:10.1002/14651858.CD002127.pub2. பப்மெட்:16235298.
Johnson KP (2007). "Control of multiple sclerosis relapses with immunomodulating agents". J. Neurol. Sci. 256 (Suppl 1): S23–8. doi:10.1016/j.jns.2007.01.060. பப்மெட்:17350652.
Gonsette RE (2007). "Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis". Expert opinion on pharmacotherapy 8 (8): 1103–16. doi:10.1517/14656566.8.8.1103. பப்மெட்:17516874.
Murray TJ (2006). "The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks?". Expert opinion on drug safety 5 (2): 265–74. doi:10.1517/14740338.5.2.265. பப்மெட்:16503747.
Leary SM, Thompson AJ (2005). "Primary progressive multiple sclerosis: current and future treatment options". CNS drugs 19 (5): 369–76. doi:10.2165/00023210-200519050-00001. பப்மெட்:15907149.
Sládková T, Kostolanský F (2006). "The role of cytokines in the immune response to influenza A virus infection". Acta Virol. 50 (3): 151–62. பப்மெட்:17131933.
Fox EJ (2006). "Management of worsening multiple sclerosis with mitoxantrone: a review". Clinical therapeutics 28 (4): 461–74. doi:10.1016/j.clinthera.2006.04.013. பப்மெட்:16750460.
Kleinschmidt-DeMasters BK, Tyler KL (2005). "Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis". N Engl J Med 353 (4): 369–74. doi:10.1056/NEJMoa051782. பப்மெட்:15947079. பதிவு செய்தால் இலவச முழு உரை
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005). "Progressive multifocal leukoencephalopathy in a patient treated with natalizumab". N Engl J Med 353 (4): 375–81. doi:10.1056/NEJMoa051847. பப்மெட்:15947078. http://content.nejm.org/cgi/content/abstract/353/4/375.
Kesselring J, Beer S (2005). "Symptomatic therapy and neurorehabilitation in multiple sclerosis". Lancet neurology 4 (10): 643–52. doi:10.1016/S1474-4422(05)70193-9. பப்மெட்:16168933.
Khan F, Turner-Stokes L, Ng L, Kilpatrick T (2007). "Multidisciplinary rehabilitation for adults with multiple sclerosis". Cochrane Database Syst Rev (2): CD006036. doi:10.1002/14651858.CD006036.pub2. பப்மெட்:17443610.
Khan F, Ng L, Turner-Stokes L (2009). "Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis". Cochrane Database Syst Rev (1): CD007256. doi:10.1002/14651858.CD007256.pub2. பப்மெட்:19160331.
Thomas PW, Thomas S, Hillier C, Galvin K, Baker R (2006). "Psychological interventions for multiple sclerosis". Cochrane Database Syst Rev (1): CD004431. doi:10.1002/14651858.CD004431.pub2. பப்மெட்:16437487.
Farinotti M, Simi S, Di Pietrantonj C, et al. (2007). "Dietary interventions for multiple sclerosis". Cochrane database of systematic reviews (Online) (1): CD004192. doi:10.1002/14651858.CD004192.pub2. பப்மெட்:17253500.
Chong MS, Wolff K, Wise K, Tanton C, Winstock A, Silber E (2006). "Cannabis use in patients with multiple sclerosis". Mult. Scler. 12 (5): 646–51. doi:10.1177/1352458506070947. பப்மெட்:17086912.
Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ (2005). "Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up". J. Neurol. Neurosurg. Psychiatr. 76 (12): 1664–9. doi:10.1136/jnnp.2005.070136. பப்மெட்:16291891.
Bennett M, Heard R (2004). "Hyperbaric oxygen therapy for multiple sclerosis". Cochrane database of systematic reviews (Online) (1): CD003057. doi:10.1002/14651858.CD003057.pub2. பப்மெட்:14974004.
Oken BS, Kishiyama S, Zajdel D, et al. (2004). "Randomized controlled trial of yoga and exercise in multiple sclerosis". Neurology 62 (11): 2058–64. பப்மெட்:15184614.
Phadke JG (May 1987). "Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland". J. Neurol. Neurosurg. Psychiatr. 50 (5): 523–31. doi:10.1136/jnnp.50.5.523. பப்மெட்:3495637.
Stern M (February 2005). "Aging with multiple sclerosis". Phys Med Rehabil Clin N Am 16 (1): 219–34. doi:10.1016/j.pmr.2004.06.010. பப்மெட்:15561552.
Myhr KM, Riise T, Vedeler C, et al (February 2001). "Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension". Mult. Scler. 7 (1): 59–65. பப்மெட்:11321195. http://msj.sagepub.com/cgi/pmidlookup?view=long&pmid=11321195. பார்த்த நாள்: 2009-12-28.
Brissaud O, Palin K, Chateil JF, Pedespan JM (September 2001). "Multiple sclerosis: pathogenesis and manifestations in children" (in French). Arch Pediatr 8 (9): 969–78. doi:10.1016/S0929-693X(01)00564-4. பப்மெட்:11582940.
Alonso A, Hernán MA (July 2008). "Temporal trends in the incidence of multiple sclerosis: a systematic review". Neurology 71 (2): 129–35. doi:10.1212/01.wnl.0000316802.35974.34. பப்மெட்:18606967.
Aladro Y, Alemany MJ, Pérez-Vieitez MC, et al (2005). "Prevalence and incidence of multiple sclerosis in Las Palmas, Canary Islands, Spain". Neuroepidemiology 24 (1-2): 70–5. doi:10.1159/000081052. பப்மெட்:15459512.
Pugliatti M, Sotgiu S, Solinas G, Castiglia P, Rosati G (April 2001). "Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory". Neurol. Sci. 22 (2): 163–5. doi:10.1007/s100720170017. பப்மெட்:11603620. http://link.springer-ny.com/link/service/journals/10072/bibs/1022002/10220163.htm. ^{[தொடர்பிழந்த இணைப்பு]}
Hammond SR, English DR, McLeod JG (May 2000). "The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia". Brain 123 (Pt 5): 968–74. doi:10.1093/brain/123.5.968. பப்மெட்:10775541. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=10775541.
Rothwell PM, Charlton D (1998). "High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition". J. Neurol. Neurosurg. Psychiatr. 64 (6): 730–5. doi:10.1136/jnnp.64.6.730. பப்மெட்:9647300. https://archive.org/details/sim_journal-of-neurology-neurosurgery-and-psychiatry_1998-06_64_6/page/730.
Compston A (October 1988). "The 150th anniversary of the first depiction of the lesions of multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 51 (10): 1249–52. doi:10.1136/jnnp.51.10.1249. பப்மெட்:3066846.
Medaer R (September 1979). "Does the history of multiple sclerosis go back as far as the 14th century?". Acta Neurol. Scand. 60 (3): 189–92. பப்மெட்:390966.
Holmøy T (2006). "A Norse contribution to the history of neurological diseases". Eur. Neurol. 55 (1): 57–8. doi:10.1159/000091431. பப்மெட்:16479124.
Pearce JM (2005). "Historical descriptions of multiple sclerosis". Eur. Neurol. 54 (1): 49–53. doi:10.1159/000087387. பப்மெட்:16103678.
The CAMMS223 Trial Investigators (2008). "Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis". N Engl J Med 359 (17): 1786–1801. doi:10.1056/NEJMoa0802670. பப்மெட்:18946064.
Polman C, Barkhof F, Sandberg-Wollheim M, Linde A, Nordle O, Nederman T (2005). "Treatment with laquinimod reduces development of active MRI lesions in relapsing MS". Neurology 64 (6): 987–91. doi:10.1212/01.WNL.0000154520.48391.69 (inactive 2009-04-04) . பப்மெட்:15781813.
Darlington CL (2005). "Technology evaluation: NeuroVax, Immune Response Corp". Curr. Opin. Mol. Ther. 7 (6): 598–603. பப்மெட்:16370383.
Agrawal YP (2005). "Low dose naltrexone therapy in multiple sclerosis". Med. Hypotheses 64 (4): 721–4. doi:10.1016/j.mehy.2004.09.024. பப்மெட்:15694688.
Gironi M, Martinelli-Boneschi F, Sacerdote P, Solaro C, Zaffaroni M, Cavarretta R, Moiola L, Bucello S, Radaelli M, Pilato V, Rodegher M, Cursi M, Franchi S, Martinelli V, Nemni R, Comi G, Martino G (2008). "A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.". Multiple Sclerosis 14 (8): 1076–83. doi:10.1177/1352458508095828. பப்மெட்:18728058.
Albrecht P, Fröhlich R, Hartung HP, Kieseier BC, Methner A (2007). "Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis". J Neurol Online (11): 1595. doi:10.1007/s00415-007-0538-3. பப்மெட்:17987252.
Gordon-Lipkin E, Chodkowski B, Reich DS et al (October 2007). "Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis". Neurology 69 (16): 1603–09. doi:10.1212/01.wnl.0000295995.46586.ae. பப்மெட்:17938370.
Zamboni P, Galeotti R, Menegatti E, et al. (April 2009). "Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 80 (4): 392–9. doi:10.1136/jnnp.2008.157164. பப்மெட்:19060024. பப்மெட் சென்ட்ரல்:2647682. http://jnnp.bmj.com/cgi/content/full/80/4/392.
Thangarajh M, Gomez-Rial J, Hedström AK, et al (August 2008). "Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis". Mult. Scler. 14 (9): 1208. doi:10.1177/1352458508095729. பப்மெட்:18755821.

pubmedcentral.nih.gov

Hainfellner JA, Schmidbauer M, Schmutzhard E, Maier H, Budka H (December 1992). "Devic's neuromyelitis optica and Schilder's myelinoclastic diffuse sclerosis". J. Neurol. Neurosurg. Psychiatr. 55 (12): 1194–6. doi:10.1136/jnnp.55.12.1194. பப்மெட்:1343820.
Buljevac D, Hop WC, Reedeker W, et al (September 2003). "Self reported stressful life events and exacerbations in multiple sclerosis: prospective study". BMJ 327 (7416): 646. doi:10.1136/bmj.327.7416.646. பப்மெட்:14500435.
Sibley WA, Bamford CR, Clark K, Smith MS, Laguna JF (July 1991). "A prospective study of physical trauma and multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 54 (7): 584–9. doi:10.1136/jnnp.54.7.584. பப்மெட்:1895121.
Smith KJ, McDonald WI (October 1999). "The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease". Philos. Trans. R. Soc. Lond., B, Biol. Sci. 354 (1390): 1649–73. doi:10.1098/rstb.1999.0510. பப்மெட்:10603618.
Anaya JM, Gómez L, Castiblanco J (2006). "Is there a common genetic basis for autoimmune diseases?". Clin. Dev. Immunol. 13 (2-4): 185–95. doi:10.1080/17402520600876762. பப்மெட்:17162361.
Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M (February 1966). "Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation". J. Neurol. Neurosurg. Psychiatr. 29 (1): 60–8. doi:10.1136/jnnp.29.1.60. பப்மெட்:5910580.
Lünemann JD, Kamradt T, Martin R, Münz C (July 2007). "Epstein-barr virus: environmental trigger of multiple sclerosis?". J. Virol. 81 (13): 6777–84. doi:10.1128/JVI.00153-07. பப்மெட்:17459939.
van der Mei IA, Ponsonby AL, Dwyer T, et al (August 2003). "Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study". BMJ 327 (7410): 316. doi:10.1136/bmj.327.7410.316. பப்மெட்:12907484.
Ge Y, Zohrabian VM, Grossman RI. (2008). "Seven-tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis". Archives of neurology 65 (6): 812–6. doi:10.1001/archneur.65.6.812. பப்மெட்:18541803.
Phadke JG (May 1987). "Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland". J. Neurol. Neurosurg. Psychiatr. 50 (5): 523–31. doi:10.1136/jnnp.50.5.523. பப்மெட்:3495637.
Compston A (October 1988). "The 150th anniversary of the first depiction of the lesions of multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 51 (10): 1249–52. doi:10.1136/jnnp.51.10.1249. பப்மெட்:3066846.

nlm.nih.gov

வாய்வழி மருந்தாக மெத்தில் ப்ரெட்னிசொலோன். யூ எஸ் நேஷனல் மருத்துவ நூலகம் (மெட்லைன்) (2003-04-01). 2007-11-22இல் திரும்ப எடுக்கப்பட்டது.
மெத்தில் ப்ரெட்னிசொலோன் சோடியம் சக்சினேட் ஊசி. யூ எஸ் நேஷனல் மருத்துவ நூலகம் (மெட்லைன்) (2003-04-01). 2007-11-22இல் திரும்ப எடுக்கப்பட்டது.

oxfordjournals.org

brain.oxfordjournals.org

Confavreux C (May 2002). "Infections and the risk of relapse in multiple sclerosis". Brain 125 (Pt 5): 933–4. doi:10.1093/brain/awf146. பப்மெட்:11960883. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11960883.
Buljevac D, Flach HZ, Hop WC, et al (May 2002). "Prospective study on the relationship between infections and multiple sclerosis exacerbations". Brain 125 (Pt 5): 952–60. doi:10.1093/brain/awf098. பப்மெட்:11960885. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=11960885.
Hammond SR, English DR, McLeod JG (May 2000). "The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia". Brain 123 (Pt 5): 968–74. doi:10.1093/brain/123.5.968. பப்மெட்:10775541. http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=10775541.

pdl.com

டேக்லிசூமாப். பிடிஎல் பயோஃபார்மா (2006-01-01). 2007-11-22இல் திரும்ப எடுக்கப்பட்டது.

primetherapeutics.com

ப்ரைம் தெரப்யூடிக்ஸ் - எப் டி ஏ கருத்துப்படி பலத்த கல்லீரல் சேதம் - ப்ரைம் தெரப்யூடிக்ஸ் பரணிடப்பட்டது 2009-10-02 at the வந்தவழி இயந்திரம்

pubmedcentral.gov

Kurtzke JF (October 1993). "Epidemiologic evidence for multiple sclerosis as an infection". Clin. Microbiol. Rev. 6 (4): 382–427. பப்மெட்:8269393. பப்மெட் சென்ட்ரல்:358295. http://cmr.asm.org/cgi/pmidlookup?view=long&pmid=8269393. பார்த்த நாள்: 2009-12-28.
Zamboni P, Galeotti R, Menegatti E, et al. (April 2009). "Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis". J. Neurol. Neurosurg. Psychiatr. 80 (4): 392–9. doi:10.1136/jnnp.2008.157164. பப்மெட்:19060024. பப்மெட் சென்ட்ரல்:2647682. http://jnnp.bmj.com/cgi/content/full/80/4/392.

rcplondon.ac.uk

The Royal College of Physicians (2004). Multiple Sclerosis. National clinical guideline for diagnosis and management in primary and secondary care (PDF). Salisbury, Wiltshire: Sarum ColourView Group. ISBN 1 86016 182 0. இலவச முழு உரை (2004-08-13). 2006-10-01இல் திரும்ப எடுக்கப்பட்டது.